7444-29-3
Chemical Structure
Anhydroleucovorin
- CAS No.: 7444-29-3
- Formula:C20H21N7O6
- Molecular Weight:455.42
IUPAC Name: (S)-2-(4-((R)-3-amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8-ium-8-yl)benzamido)-4-carboxybutanoate
InChIKey: MEANFMOQMXYMCT-OLZOCXBDSA-N
SMILES: O=C1C2=C(NC(N)=N1)NC[C@@]3([H])N2C=[N+](C4=CC=C(C=C4)C(N[C@H](C([O-])=O)CCC(O)=O)=O)C3
Biological Activity: Anhydroleucovorin is a form of tetrahydrofolate and serves as a substrate for cyclohydrolase, which converts it to 10-formyltetrahydrofolate. Anhydroleucovorin can be used in oncology research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Anhydroleucovorin | 96.6% | Anhydroleucovorin is a form of tetrahydrofolate and serves as a substrate for cyclohydrolase, which converts it to 10-formyltetrahydrofolate. Anhydroleucovorin can be used in oncology research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Anhydroleucovorin (Standard) | ≥98% | Anhydroleucovorin (Standard) is the analytical standard of Anhydroleucovorin (HY-153039). This product is intended for research and analytical applications. Anhydroleucovorin is a form of tetrahydrofolate and serves as a substrate for cyclohydrolase, which converts it to 10-formyltetrahydrofolate. Anhydroleucovorin can be used in oncology research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.69
HY-14769Folitixorin -
Similarity Score 0.69
HY-109051AArfolitixorin calcium -
Similarity Score 0.69
HY-14769AFolitixorin calcium -
Similarity Score 0.69
HY-113046R5-Methyltetrahydrofolic acid (Standard) -
Similarity Score 0.69
HY-113046S15-Methyltetrahydrofolic acid-13C6 -
Similarity Score 0.69
HY-14781Levomefolic acid -
Similarity Score 0.69
HY-14781S2Levomefolic acid-13C5 -
Similarity Score 0.68
HY-14781ALevomefolic acid magnesium -
Similarity Score 0.67
HY-101943RLY 345899 (Standard) -
Explore the MedChemAI to find more analogs